Quidelortho (QDEL) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 
Quidelortho Corp  (NASDAQ: QDEL)
 

Quidelortho Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the second quarter 2026, Quidelortho's inventory turnover ratio sequentially decreased to 2.45 in the second quarter 2026, unsurprisingly, as the Quidelortho markets continue to deteriorate, and QDEL's faces growing challenges to bring down its inventories. Quidelortho's average inventory processing period in the Jun 28 2026 quarter, has increased to 149 days, from 148 days, in the Mar 29 2026 quarter.

Within Healthcare sector 157 other companies have achieved higher inventory turnover ratio. While inventory turnover ranking remained unchanged in the Second Quarter 2026 compared to previous quarter at no. 532.

QDEL Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Quidelortho Corp Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

QDEL Inventory Turnover Ratio (Jun 28 2026)
II. Quarter		 (Mar 29 2026)
I. Quarter		 (Dec 28 2025)
IV. Quarter		 (Sep 28 2025)
III. Quarter		 (Jun 29 2025)
II. Quarter
Y / Y Inventory Growth 6.95 % 8.58 % 8.23 % 6.38 % -3.87 %
Y / Y Cost of Sales Growth 5.6 % 1.86 % 5.63 % -2.8 % -6.09 %
Inventory Turnover Ratio (TTM) 2.45 2.46 2.5 2.51 2.57
QDEL's Total Ranking # 532 # 532 # 830 # 1151 # 1204
Average inventory processing period 149 149 146 146 142
Seq. Inventory Growth 1.21 % 5.87 % -5.9 % 6.07 % 2.75 %
Seq. Cost of Sales Growth 0.56 % -11.71 % 10.68 % 7.46 % -3 %




Inventory Turnover Ratio Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry # 8
Healthcare Sector # 158
Overall Market # 532

Inventory Turnover Ratio Statistics
High Average Low
3.76 2.89 2.17
(Jun 30 2012)   (Dec 31 2021)



QDEL Company Profile >> Back to QDEL Efficiency Comparisons >> Compare QDEL Inventory Turnover Ratio to its Competitors

Financial Statements
Quidelortho's Inventories $ 619 Millions Visit QDEL's Balance sheet
Quidelortho's Cost of Revenues TTM $ 1,482 Millions Visit QDEL's Income Statement
What are QDEL's Sales? Visit QDEL's Sales by Segment

Other Inventory Turnover Ratios
Quidelortho's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
In Vitro & In Vivo Diagnostic Substances Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
QDEL's Inventory Turnover Ratio versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for QDEL's Competitors
Inventory Turnover Ratio for QDEL's Suppliers
Inventory Turnover Ratio for QDEL's Customers

You may also want to know
QDEL's Sales Growth Rates QDEL's Pe Price to earnings ratio QDEL's Receivables Turnover Ratio QDEL's Stock Quote
QDEL's Net Income Growth Rates QDEL's Ps Price to Sales ratio QDEL's Sales per Employee QDEL's Asset Turnover Ratio
QDEL's Net Margin QDEL's Pb Price to Book ratio QDEL's Financial Strength Ratios QDEL's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 28 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 28 2026 Inventories at quarter ending Jun 28 2026
Brightspring Health Services Inc   6.35 $ 4,108.953  Millions$ 647  Millions
Puma Biotechnology Inc   6.29 $ 58.199  Millions$ 9  Millions
Kewaunee Scientific Corporation  6.12 $ 196.836  Millions$ 32  Millions
Adm Tronics Unlimited Inc   6.05 $ 1.970  Millions$ 0  Millions
Align Technology inc   6.00 $ 1,321.762  Millions$ 220  Millions
Sharps Technology Inc   5.68 $ 2.869  Millions$ 1  Millions
Transmedics Group Inc   5.59 $ 276.120  Millions$ 49  Millions
Cg Oncology Inc   5.47 $ 7.609  Millions$ 1  Millions
Opko Health Inc   5.42 $ 348.206  Millions$ 64  Millions
Charles River Laboratories International inc   5.39 $ 1,761.363  Millions$ 327  Millions
Bristol myers Squibb Company  5.37 $ 14,678.000  Millions$ 2,735  Millions
Tactile Systems Technology Inc   5.12 $ 81.349  Millions$ 16  Millions
Integer Holdings Corporation  5.03 $ 1,369.168  Millions$ 272  Millions
Collegium Pharmaceutical Inc   4.99 $ 293.290  Millions$ 59  Millions
Harrow Inc   4.93 $ 73.636  Millions$ 15  Millions
Ufp Technologies Inc   4.93 $ 452.046  Millions$ 92  Millions
Veracyte Inc   4.84 $ 102.741  Millions$ 21  Millions
West Pharmaceutical Services Inc   4.72 $ 2,103.100  Millions$ 445  Millions
Henry Schein Inc   4.68 $ 9,342.000  Millions$ 1,997  Millions
Guardant Health Inc   4.53 $ 413.947  Millions$ 91  Millions
Idexx Laboratories Inc  4.44 $ 1,714.440  Millions$ 386  Millions
Cryoport inc   4.40 $ 98.679  Millions$ 22  Millions
Envista Holdings Corporation  4.37 $ 1,278.500  Millions$ 293  Millions
Vericel Corporation  4.30 $ 77.922  Millions$ 18  Millions
Myomo Inc   4.23 $ 14.262  Millions$ 3  Millions
Adc Therapeutics Sa  4.17 $ 5.806  Millions$ 1  Millions
Scilex Holding Company  4.08 $ 14.867  Millions$ 4  Millions
Medinotec Inc   4.08 $ 4.736  Millions$ 1  Millions
Alpha Teknova Inc   4.08 $ 28.288  Millions$ 7  Millions
3m Company  4.07 $ 15,258.000  Millions$ 3,754  Millions

Date modified: 2026-09-08T20:21:11+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.